MedPath

SIMPONI I.V.

SIMPONI I.V.

Approved
DIN Number

02417472

Drug Class

Human

Market Date

Dec 12, 2013

Company
HC

Janssen Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02417472
AIG Number0152549002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L04AB06 GOLIMUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification90:24.16.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

GOLIMUMABActive
Strength: 50 MG / 4.0 ML
Monograph: GOLIMUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.